PharmEasy’s ₹5,000 Crore Mistake ?
PharmEasy’s ₹5,000 Crore Mistake ?
-------------------------------------------
Learn Finance For Free - https://www.youtube.com/@Adityasainifinance
-------------------------------------------
PharmEasy’s ₹5,000 Crore Mistake 😱 | How India’s Healthtech Star Lost Its Way
Once hailed as India’s healthtech unicorn, PharmEasy was valued at over ₹50,000 Crore. But now? The company is struggling under massive debt, IPO delays, and what many are calling a ₹5,000 Cr blunder. So what really happened?
In this video, we break down the real story behind PharmEasy’s downfall — the aggressive moves, the flawed acquisition, and the cash burn that pushed them to the edge.
📉 What You’ll Learn:
– PharmEasy’s epic rise & unicorn status
– The Thyrocare acquisition – bold move or bad call?
– How funding winters exposed deeper cracks
– What went wrong with their IPO plan
– Lessons every founder & investor must learn
Whether you're in startups, investing, or healthcare, this story is a masterclass in risk, scale, and strategy — and what not to do.
💊 This isn’t just a startup story. It’s a warning.
Видео PharmEasy’s ₹5,000 Crore Mistake ? канала Aditya Saini Business
-------------------------------------------
Learn Finance For Free - https://www.youtube.com/@Adityasainifinance
-------------------------------------------
PharmEasy’s ₹5,000 Crore Mistake 😱 | How India’s Healthtech Star Lost Its Way
Once hailed as India’s healthtech unicorn, PharmEasy was valued at over ₹50,000 Crore. But now? The company is struggling under massive debt, IPO delays, and what many are calling a ₹5,000 Cr blunder. So what really happened?
In this video, we break down the real story behind PharmEasy’s downfall — the aggressive moves, the flawed acquisition, and the cash burn that pushed them to the edge.
📉 What You’ll Learn:
– PharmEasy’s epic rise & unicorn status
– The Thyrocare acquisition – bold move or bad call?
– How funding winters exposed deeper cracks
– What went wrong with their IPO plan
– Lessons every founder & investor must learn
Whether you're in startups, investing, or healthcare, this story is a masterclass in risk, scale, and strategy — and what not to do.
💊 This isn’t just a startup story. It’s a warning.
Видео PharmEasy’s ₹5,000 Crore Mistake ? канала Aditya Saini Business
Показать
Комментарии отсутствуют
Информация о видео
2 апреля 2025 г. 20:00:06
00:21:48
Другие видео канала




















